Skip to main content

$0.062 0.002 (3.33%)

High

$0.06

Low

$0.06

Trades

18

Turnover

$32,113

Volume

526,676
30 June 2023 at 3:59pm
Register to track DXB and receive email alerts.

Dimerix Confirms Phase 3 FSGS Study Design With EMA

StockBot

416,823 posts

DXB released this announcement to the ASX on 3 June 2021, 9:41. The announcement is marked as price sensitive, and is 3 page(s) in length and 297.79kb in size.

You can view all announcements from DXB and see how they appear on a price chart on the announcements page.

At the date of this announcement, DXB was 0.009% short sold according to ASIC data. It was ranked the 578th most shorted stock on the ASX. It is now ranked as the 444th most shorted stock on the ASX with 0.114% of total shares short sold as of the latest reported data (26 May 2026).

Other Recent Announcements from DXB
Application for quotation of securities - DXB 29 June 2023, 9:01
Application for quotation of securities - DXB 29 June 2023, 9:00
Application for quotation of securities - DXB 29 June 2023, 8:59
Dimerix Confirms Phase 3 FSGS Study Design With EMA 3 June 2021, 9:41
DMX-200 Remains Eligible for Accelerated Approval 27 May 2021, 10:28
Investor Presentation 25 May 2021, 9:13
Update of DMX-200 Study in COVID-19 Patients in India 12 May 2021, 9:43
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track DXB and receive email alerts.